Daniel N. Swisher, Jr

2018 - Jazz Pharmaceuticals

In 2018, Daniel N. Swisher, Jr earned a total compensation of $5.8M as President and COO at Jazz Pharmaceuticals.

Compensation breakdown

Bonus$125,000
Non-Equity Incentive Plan$400,000
Option Awards$2,075,162
Salary$608,173
Stock Awards$2,532,058
Other$12,948
Total$5,753,341

Swisher received $2.5M in stock awards, accounting for 44% of the total pay in 2018.

Swisher also received $125K in bonus, $400K in non-equity incentive plan, $2.1M in option awards, $608.2K in salary and $12.9K in other compensation.

Rankings

In 2018, Daniel N. Swisher, Jr's compensation ranked 1,659th out of 14,244 executives tracked by ExecPay. In other words, Swisher earned more than 88.4% of executives.

ClassificationRankingPercentile
All
1,659
out of 14,244
88th
Division
Manufacturing
592
out of 5,765
90th
Major group
Chemicals And Allied Products
188
out of 2,128
91st
Industry group
Drugs
149
out of 1,817
92nd
Industry
Pharmaceutical Preparations
110
out of 1,391
92nd

Pay ratio

Daniel N. Swisher, Jr's Pay$5,753,341
Median Employee's Pay$216,797
Pay Ratio

27

to 1

In 2018, the annual total compensation of Daniel N. Swisher, Jr was $5,753,341.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $216,797.

The ratio of Daniel N. Swisher, Jr's pay to the pay of median employee was therefore 27 to one.

Source: SEC filing on June 14, 2019.

Swisher's colleagues

We found four more compensation records of executives who worked with Daniel N. Swisher, Jr at Jazz Pharmaceuticals in 2018.

2018

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2018

Suzanne Hooper

Jazz Pharmaceuticals

Former Executive Vice President and GC

2018

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2018

Michael Miller

Jazz Pharmaceuticals

Executive Vice President U.S Commercial

News

You may also like